Judge deems antitrust suit to be outside arbitration
Credit: Luis García (https://es.m.wikipedia.org/wiki/Archivo%3AJohnson_%26_Johnson_offices_in_Madrid_%28Spain%29_01.jpg)
A federal district court has ruled Johnson & Johnson and Janssen Biotech cannot force individual arbitration of antitrust claims brought by a class of direct purchasers of Remicade.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is the complete source of news and analysis for competition practitioners. It keeps you up to speed with the issues and trends that matter, giving you the detail, and depth, you need to operate successfully.
Subscribe now
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10